Augmentin 250 mg/125 mg film-coated tablets
- Name:
Augmentin 250 mg/125 mg film-coated tablets
- Company:
GlaxoSmithKline (Ireland) Ltd
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may not be renewed (A)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 28/01/19
(Click to Download)Click on this link to Download PDF directly
GlaxoSmithKline (Ireland) Ltd
 Ltd.jpg)
Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 2 July 2019 SmPC
Reasons for updating
- File format updated to PDF
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
File format updated to PDF. SPC approved on 28 February 2018.
Updated on 28 January 2019 PIL
Reasons for updating
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
- Change to other sources of information section
Updated on 1 June 2018 SmPC
Reasons for updating
- New SmPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 21 May 2018 SmPC
Reasons for updating
- Change to section 4.1 - Therapeutic indications
- Change to section 4.2 - Posology and method of administration
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.6 - Pregnancy and lactation
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 4.9 - Overdose
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 5.2 - Pharmacokinetic properties
- Change to section 6.2 - Incompatibilities
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 16 May 2018 SmPC
Reasons for updating
- Other
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 16 May 2018 SmPC
Reasons for updating
- Other
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 16 May 2018 SmPC
Reasons for updating
- Other
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 16 May 2018 SmPC
Reasons for updating
- Other
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 11 May 2018 SmPC
Reasons for updating
- New SmPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Reason for Update: Update to SPC, PIL and labelling in line with HU comments, absorption statements and QRD 10 - combination with Type IB WS to include PRAC recommendation on DRESS
Agency Approval Date: 28/02/2018
Text Date: 23/10/2017
Issue No.: 5
Draft No.: 1
Updated on 6 March 2018 PIL
Reasons for updating
- Change to section 6 - date of revision
- Change to section 4 - possible side effects
Updated on 6 March 2018 PIL
Reasons for updating
- New PIL for new product
Updated on 31 October 2017 PIL
Reasons for updating
- Change to section 2 - what you need to know - contraindications
- Change to section 3 - how to take/use
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
- Improved presentation of PIL
Updated on 16 July 2015 PIL
Reasons for updating
- Change to date of revision
- Change to MA holder contact details
Updated on 26 June 2015 PIL
Reasons for updating
- Change to date of revision
- Addition of information on reporting a side effect.
- Correction of spelling/typing errors
Updated on 29 January 2014 PIL
Reasons for updating
- Change to storage instructions
- Change to side-effects
- Change to drug interactions
Updated on 2 November 2010 PIL
Reasons for updating
- Change due to harmonisation of PIL
- Change due to user-testing of patient information
Updated on 24 June 2008 PIL
Reasons for updating
- Change of trade or active ingredient name
- Change to storage instructions
Updated on 15 March 2007 PIL
Reasons for updating
- Improved electronic presentation
Updated on 26 October 2006 PIL
Reasons for updating
- Change to side-effects
Updated on 18 August 2004 PIL
Reasons for updating
- New PIL for medicines.ie